SELLAS Life Sciences Group (SLS) Net Cash Flow: 2011-2024
Historic Net Cash Flow for SELLAS Life Sciences Group (SLS) over the last 8 years, with Sep 2024 value amounting to $11.9 million.
- SELLAS Life Sciences Group's Net Cash Flow rose 220.80% to $11.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $17.1 million, marking a year-over-year increase of 214.67%. This contributed to the annual value of $11.4 million for FY2024, which is 177.81% up from last year.
- According to the latest figures from Q3 2024, SELLAS Life Sciences Group's Net Cash Flow is $11.9 million, which was up 228.23% from -$9.3 million recorded in Q2 2024.
- In the past 5 years, SELLAS Life Sciences Group's Net Cash Flow ranged from a high of $27.1 million in Q4 2020 and a low of -$9.8 million during Q3 2023.
- Over the past 3 years, SELLAS Life Sciences Group's median Net Cash Flow value was -$4.2 million (recorded in 2022), while the average stood at $606,909.
- In the last 5 years, SELLAS Life Sciences Group's Net Cash Flow slumped by 1,268.93% in 2021 and then soared by 814.81% in 2022.
- Over the past 5 years, SELLAS Life Sciences Group's Net Cash Flow (Quarterly) stood at $27.1 million in 2020, then crashed by 118.18% to -$4.9 million in 2021, then grew by 14.27% to -$4.2 million in 2022, then surged by 65.92% to -$1.4 million in 2023, then soared by 220.80% to $11.9 million in 2024.
- Its Net Cash Flow stands at $11.9 million for Q3 2024, versus -$9.3 million for Q2 2024 and $15.9 million for Q1 2024.